•  
  •  
  •  
  •  

2026-05-28 19:06:16

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • The Sukhjit Starch and Chemicals Ltd delivers a Revenue Growth of 16.89% QoQ in Q4 FY26 with Optimistic Outlook
  • Power and Instrumentation Gujarat Ltd receives additional work order worth Rs. 7.13 crore
  • Corona Remedies Accelerates India and World Market Expansion with EU-GMP Accreditations for Hormone and Oral Solid Dosage Facility
  • Kissht delivers first results post-listing: FY26 PAT up 75% YoY to ₹281 Cr; AUM crosses ₹7,000 Cr milestone
  • Likhitha Infrastructure Ltd receives order worth Rs. 121.04 crores

Keywords Selected:  WindlasBiotech

IPO News

  • Windlas Biotech Ltd posts consolidated PAT of Rs. 11.44 crores in Q4FY23

Stock Report

  • Windlas Biotech Announces ₹47 Crore Share Buyback at ₹1,000 per Share
  • Windlas Biotech Limited commissions its State-of-the-Art Injectable facility
  • Windlas Biotech Ltd posts Rs. 12.06 crores consolidated net profit in Q1 FY2023-24
  • Windlas Biotech appoints Ms. Komal Gupta as CEO
  • Windlas Biotech Ltd reports consolidated PAT of Rs. 9.18 crores in Q3FY23
  • Windlas Biotech Ltd reports Rs. 12.19 crores consolidated PAT in Q2 FY2023
  • Windlas Biotech Ltd posts QoQ fall in Q1FY23 consolidated profit to Rs. 9.8 crores
  • Windlas Biotech Limited receives EU-GMP certificate
  • Windlas Biotech Limited recommends dividend of Rs. 3.50
  • Windlas Biotech Ltd Q4FY22 consolidated profit rises to Rs. 14.78 crores
  • Windlas Biotech receives certificate of Good Manufacturing Practices from SAHPRA
  • Windlas Biotech concludes EU GMP Inspection, receives 0 critical observations
  • Windlas Biotech Q3FY22 consolidated PAT at Rs. 8.31 crore
  • Windlas Biotech Limited concludes SAHPRA Audit
  • Windlas Biotech Limited Strengthens Senior Management Capability

Latest Post

  • The Sukhjit Starch and Chemicals Ltd delivers a Revenue Growth of 16.89% QoQ in Q4 FY26 with Optimistic Outlook
  • Power and Instrumentation Gujarat Ltd receives additional work order worth Rs. 7.13 crore
  • Corona Remedies Accelerates India and World Market Expansion with EU-GMP Accreditations for Hormone and Oral Solid Dosage Facility
  • Kissht delivers first results post-listing: FY26 PAT up 75% YoY to ₹281 Cr; AUM crosses ₹7,000 Cr milestone
  • Likhitha Infrastructure Ltd receives order worth Rs. 121.04 crores


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
C-4, Podhigai Flats, Pillayar Koil Street, Nesapakkam
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-88776-69935
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
Nesapakkam, Chennai - 600 078,
Tamil Nadu, India

Disclaimer Copyright © - 2025